Ranbaxy is a pharmaceutical company providing a diverse range of affordable and high-quality medicine globally. It began operations in India, and then it expanded to several other countries, including the United States, Europe, and Japan.
Ranbaxy Laboratories was founded in 1961 by Ranbir Singh and Gurbax Singh in Amritsar, India.
The company expanded rapidly and diversified into several areas, including fine chemicals, crop protection, and diagnostics.
In 2008, Japanese pharmaceutical company Daiichi Sankyo acquired a majority stake in Ranbaxy Laboratories Limited, and later purchased the entire company in 2014.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company. It provides generic, formulating, and API manufacturing solutions globally.
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company. It produces and provides pharmaceutical products and services, including generic drugs, active ingredients, biosimilars, custom pharmaceutical services, and branded formulations.
Cipla Limited is a multinational pharmaceutical company that develops, manufactures, and distributes prescription drugs, generic pharmaceuticals, and active pharmaceutical ingredients (APIs).
Atorvastatin is a statin medication used for treating high cholesterol. It is a generic version of Lipitor and is produced by Ranbaxy.
Ciprofloxacin is an antibiotic medication used for treating infections caused by bacteria. It is a generic version of Cipro and is produced by Ranbaxy.
Gabapentin is a medication used for treating seizures and nerve pain. It is a generic version of Neurontin and is produced by Ranbaxy.
Ranbaxy is known for producing affordable and high-quality generic versions of drugs used for various chronic and acute health conditions.
Yes, Ranbaxy is a reliable and reputable pharmaceutical company that produces high-quality generic drugs. However, its ownership has changed over the years, and it may have experienced some quality issues in the past.
Ranbaxy produces several popular generic drugs, including atorvastatin (generic Lipitor), ciprofloxacin (generic Cipro), and gabapentin (generic Neurontin).
Ranbaxy's products are manufactured in several countries, including India, the United States, and several other locations worldwide.
Daiichi Sankyo acquired a majority stake in Ranbaxy Laboratories Limited in 2008 and later purchased the entire company in 2014.
